As per the report, the size of the global clinical nutrition market is projected to grow USD 17.1 Billion by 2025 from USD 14.0 Billion in 2020. This market is estimated to be growing at a CAGR of 4.13% during the forecast period.
Clinical nutrition aids in improving absorption, metabolism, digestion, and discharge functions by providing essential nutrients such as minerals, vitamins, and proteins. These products are vital for patients with a high degree of malnourishment, patients in intensive care units, patients recovering from trauma or surgery, and patients suffering from chronic diseases. It has been found that treating disease-related malnutrition with clinical nutrition therapies can reduce mortality.
Clinical nutrition is necessary for patients who are facing nutritional deficiency or unable to consume food due to enhanced disease conditions, which can lead to lower quality of life, the risk of complications, increased risk of mortality, and lengthening of a recovery period. Clinical nutrition plays a vital role in maintaining nutritional imbalance for malnourished patients who have a higher risk of complications because of a lack of nutrition.
Rising incidence of metabolic disorders and increased expenditure on healthcare are favoring the growth of the clinical nutrition market.
Major drivers for the global clinical nutrition market are a shift towards home care, increasing the prevalence of chronic diseases, rising aged population, and an increasing number of premature births. Sustained support from government agencies and investments made by manufacturers are also supporting the market growth. Clinical nutrition therapies at home have become possible due to technological innovation.
The factors such as the expansion of the healthcare sector, the emergence of innovative products into the market, awareness programs by private and public institutions, high occurrence of neurological diseases, and reimbursement policies are expected to propel growth opportunities of the clinical nutrition market.
The need to make up for the safety and quality standards of nutritional therapies is acting as a restraint for the global clinical nutrition market.
Market Size Available
2019 to 2025
2020 to 2025
By Route Of Administration, Therapeutic Areas, Ingredients Type, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
This market research report on the global clinical nutrition market has been segmented based on the route of administration, therapeutic areas, ingredients type, and region.
Clinical Nutrition Market Analysis - By Route of Administration
Based on the route of administration, the Oral clinical nutrition segment is dominating the market as the Enteral and parenteral segments are expensive, which is due to expenses involved in the processing of nutrients or products. The oral segment accounted for the largest share in 2018 and is expected to continue the trend throughout the forecast period. This growth is attributed to its extensive usage in patients owing to its easy intake and availability for several diseases.
Clinical Nutrition Market Analysis - By Therapeutic Areas
Based on therapeutic areas, the Diabetes segment is ruling the clinical nutrition market owing to the increase in the rate of diabetic patients in recent years. The cancer market segment was growing rapidly with a high CAGR and expected to contribute a significant share during the forecast period.
The cancer is projected to be the fastest-growing segment during the forecast period. It is attributed to the nutritional deficiency that arises in patients due to various cancer treatments such as chemotherapy, hormone therapy, radiation therapy, surgery, immunotherapy, and stem cell transplant.
Clinical Nutrition Market Analysis - By Ingredients Type
Based on ingredients type, Vitamins segment is contributing a significant share to the clinical nutrition market and is expected to grow further during the forecast period.
Clinical Nutrition Market Analysis - By Region
Regionally, the Clinical Nutrition market in North America and Europe is rapidly growing owing to the high rate of malnutrition, increase in the population affected by various diseases. North America was the leading revenue contributor to the global clinical nutrition market in 2019 and is anticipated to dominate the market during the forecast period, due to upsurge in several chronic diseases such as coronary artery disease, ischemic stroke, diabetes, and few cancer indications, and increase in the geriatric population. Besides, the initiative taken by the U.S. government to promote complete nutrition care for cancer patients is anticipated to drive the market further. However, Asia-Pacific is expected to experience the fastest CAGR during the forecast period, due to an increase in metabolic disorders, high disposable incomes, and improvement in patient awareness regarding the adoption of clinical nutrition products.
The Asia Pacific region is ruling the Global Clinical nutrition market by contributing a significant share in revenue due to an increase in birth rates, a rise in the geriatric population, increasing chronic conditions in patients, unhealthy food habits.
Asia-Pacific has the highest growth, in comparison to the other regions, in the forecast period. The major factors attributing to the growth of the Asia Pacific clinical nutrition market include an increase in the prevalence of metabolic disorders, a rise in the geriatric population in the Asia Pacific Region, and high spending on healthcare. The incidence of diabetes in China is also growing rapidly, which is a significant factor for obesity. As per the International Diabetes Federation (IDF) data, there were over 114,394,800 cases of diabetes in China in 2017, and the rate of prevalence of diabetes in adults is 10.9%. The actual number of patients undergoing diagnosis of metabolic disorders has increased over the decade; hence, there is an increase in the number of patients diagnosed in the Asia Pacific region.
The size of the Clinical Nutrition market in Europe was worth USD 3.56 Billion in 2019 and estimated to be growing at a CAGR of 7.17 % to reach USD 5.03 Billion by 2024. The European clinical nutrition market is driven by the aging population and increased disease diagnosis.
Japan's market is estimated to expand with a CAGR of 7.9% over the forecast period, owing to a large geriatric population base as well as increasing incidences of chronic conditions including diabetes mellitus and cancer due to dietary shift. The presence of associations such as the Japan Society of Nutrition and Food Science (JSNFS) working towards promoting public health and creating awareness about clinical nutrition will favor the growth of Japan market over the forecast timeframe.
Brazil's market dominated the Latin America region and was valued at around USD 1,586.6 million in the year 2018. The market growth will be driven by the increasing obese population and the growing incidences of chronic diseases. High prevalence of preterm births leading to a rise in demand for clinical nutrition will favor Brazil's market growth. Moreover, a strong association with the American Society of Parenteral and Enteral Nutrition helps the development of the clinical nutrition market in the country.
The presence of associations such as the South African Society for Enteral and Parenteral Nutrition, creating awareness about clinical nutrition in the country coupled with the growing burden of enfeebling diseases, will drive the South Africa market over the forecast timeframe. Health infrastructure development and the increasing public, as well as private players initiatives to boost sales of nutritional formulae in the country, will propel market growth.
TOP COMPANIES IN THE MARKET
Some of the key market participants in the global clinical nutrition market profiled in this report are Nestle Nutrition, Abbott Laboratories Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, Ajinomoto Co. Inc., Hospira Inc., Hero Nutritionals Inc., Lonza Ltd, Baxter International Inc., B. Braun Melsungen AG, H., J. Heinz Company, American Home Patient Inc. and Fresenius Kabi.
RECENT MARKET DEVELOPMENTS
In 2019, Nestle acquired Persona to expand its product portfolio in personalized nutrition.
In 2019, Fresenius Medical care completed the acquisition of NxStage Medical.
In 2018, Nestle bought the rights to distribute foodservice products and consumer packaged goods from Starbucks Corporation.
In the year 2019 December, BASF Nutrition & Health announced its collaboration with Idogen, a Swiss pharmaceutical company. Following the partnership, the former company launched an omega-three fatty acid solution, Hepacor, in the European market. The solution helps patients manage Non-Alcoholic Fatty Liver Disease (NAFLD) by elevating healthy lipids in the bloodstream.
In September 2019, B. Braun collaborated with Smartfish AS, a nutrition-based company. The collaboration was focused on securely launching the latter company’s medical nutrition product Remune.
In May 2019, Nestle Health Science came into partnership with Amazentis, a pioneer in science-driven nutritional health. The association was focused on developing its new cellular nutrient Urolithin A. Also; the two companies were aimed to conduct a joint research program for expanding applications of Urolithin A, a pioneering cellular nutrient that supports mitochondrial health into new consumer health and medical areas.
In October 2019, Lonza launched MuscleGuard formulation, a unique patent-pending ingredient combination. The combination comprised of a precise and clinically-studied ratio of four nutrients; Lonza’s Carnipure L-Carnitine, Creatine, and Leucine with vitamin D. MuscleGuard formulation deliver positive results for sports performance and recovery through a significant increase in muscle strength, mass, and activity.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Route of Administration
5.1.1 Oral Nutrition
5.1.2 Enteral Nutrition
5.1.3 Parenteral Nutrition
5.2 By Therapeutic Area
5.2.4 Food Allergies
5.2.7 Short-Bowel Syndrome
5.2.8 Acute Lung Injury
5.2.9 Acute Respiratory Distress
5.3 By Ingredients Type
5.3.4 Amino Acids
6. Geographical Analysis
6.1 North America
6.1.2 United States
6.3.5 South Korea
6.4 Latin America
6.4.5 Rest of Latin America
6.5 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Nestle Nutrition
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Abbott Laboratories Inc.
8.3 Gentiva Health Services Inc.
8.4 Mead Johnson & Company
8.6 Ajinomoto Co. Inc.
8.7 Hospira Inc.
8.8 Hero Nutritionals Inc.
8.9 Lonza Ltd
8.10 Baxter International Inc.
8.11 B. Braun Melsungen AG
8.12 H. J. Heinz Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
a) List of Tables
b) List of Figures